Article Information
History
- December 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Can Cui1,
- Jiawei Wang3,
- Ping-Min Chen1,
- Kelli A. Connolly1,
- Martina Damo1,
- Eric Fagerberg1,
- Shuting Chen1,
- Stephanie C. Eisenbarth1,2,4,
- Hongyu Zhao5,
- Joseph Craft1,2 and
- Nikhil S. Joshi1,*
- 1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
- 2Department of Internal Medicine (Rheumatology, Allergy and Immunology), Yale University School of Medicine, New Haven, CT 06520, USA
- 3Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA 06510, USA
- 4Department of Lab Medicine, Yale University School of Medicine, New Haven, CT 06519, USA
- 5Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA
- ↵*Corresponding author; email: nikhil.joshi{at}yale.edu
Posted December 24, 2020.
Neoantigen driven B cell and CD4+ T follicular helper cell collaboration promotes robust anti-tumor CD8+ T cell responses
